McDermott International (MDR), Petroleo Brasileiro Petrobras SA (ADR) (PBR): This $7 Turnaround Play Could Pop 40% In 6 Months

Page 1 of 2

Investing in turnaround stocks can be quite profitable if you follow one simple rule: Only focus on companies that have identified the source of their woes and have delineated clear and workable solutions to stabilize and rebuild operations.

For struggling global construction firm McDermott International (NYSE:MDR), the path to a turnaround has been spelled out for investors. Now it’s time to execute on that plan.

A quick glance at McDermott International (NYSE:MDR)’s business model suggests this company should be flourishing. It has deep expertise in the construction of massive offshore energy platforms. In recent years, major oil companies have waded deep into the Atlantic Ocean as they seek to replace the output of fast-depleting onshore oil fields. For example, the Lula oil field off the coast of Rio de Janerio might hold up to 8 billion barrels of oil and is currently being developed by Brazil’s Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR).

But McDermott International (NYSE:MDR) has stumbled badly, thanks to a series of managerial missteps. Most notably, the company has been unable to complete contracts under budget, turning potentially profitable deals into money losers. That was the result of a decision to pursue deepwater projects, straying from its core competency of shallow-water projects.

Though McDermott International (NYSE:MDR) has been underperforming for quite some time — missing profit estimates in the final two quarters of 2012 and the first quarter of 2013 — the recently released second-quarter results were bad enough to send shares down roughly 20% in just one trading session.

That was enough to lead to a shake-up at the company. A raft of senior executives, many of whom had oversight of regional projects in Asia and elsewhere, has been replaced. The company expects to take roughly $50 million in restructuring expenses, which should “mark the peak of near-term charges,” according to analysts at UBS.

The company said it intends to revisit its past strengths. Referring to recent quarterly results on the second-quarter conference call, CEO Stephen Johnson said, “We found that our processes and procedures were somewhat inconsistently applied throughout the organization and that management needs to improve adherence to our proven processes and procedures,” adding that “more experienced and more skilled personnel are now being recruited, being trained and assigned to projects by our global operations management.”

More importantly, McDermott International (NYSE:MDR) has abandoned the practice of pursuing projects at any price to retain market share. Instead, the company said it plans to pursue new contracts that are priced to better reflect potential cost overruns. It will take 12 to 18 months for bad projects to roll off the books, but the move should lead to a rebound in profit margins.

According to Morgan Stanley, McDermott’s EBITDA margins (margins on earnings before interest, taxes, depreciation and amortization) slid from 19% in 2010 to 12% in 2012, and thanks to a dismal first half of 2013, are likely to be slightly negative this year. Notably, these analysts think that newer contracts with sounder pricing will help EBITDA margins rebound to 8% in 2014 and 9% in 2015.

Of course, the only way to ensure solid pricing is a willingness to cease pursuing market share. That’s why Morgan Stanley’s analysts also see the company’s order book falling from $4.8 billion in 2012 to just $3 billion this year and again in 2014. In effect, the company is willing to shrink to grow stronger.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!